Asset Details
Do you wish to reserve the book?
Associations between lifetime classic psychedelic use and cardiometabolic diseases
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Associations between lifetime classic psychedelic use and cardiometabolic diseases
Do you wish to request the book?
Associations between lifetime classic psychedelic use and cardiometabolic diseases
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Associations between lifetime classic psychedelic use and cardiometabolic diseases
2021
Overview
The objective of the current study was to investigate the associations between lifetime classic psychedelic use and cardiometabolic diseases. Using data from the National Survey on Drug Use and Health (2005–2014), the present study examined the associations between lifetime classic psychedelic use and two types of cardiometabolic disease: heart disease and diabetes. Respondents who reported having tried a classic psychedelic at least once in their lifetime had lower odds of heart disease in the past year (adjusted odds ratio (aOR) = 0.77 (0.65–0.92), p = .006) and lower odds of diabetes in the past year (adjusted odds ratio (aOR) = 0.88 (0.78–0.99), p = .036). Classic psychedelic use might be beneficial for cardiometabolic health, but more research is needed to investigate potential causal pathways of classic psychedelics on cardiometabolic diseases.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 631/378
/ 631/477
/ 692/4019
/ 692/499
/ 692/699
/ 692/700
/ Adult
/ Cardiovascular Diseases - epidemiology
/ Diabetes
/ Diabetes Mellitus - drug therapy
/ Diabetes Mellitus - epidemiology
/ Female
/ Hallucinogens - adverse effects
/ Heart Diseases - epidemiology
/ Humanities and Social Sciences
/ Humans
/ Male
/ Science
